Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis

Clinical trial NCT04971590 · COMPLETED

Trial details

NCT number: NCT04971590
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Systemic Lupus Erythematosus

Start date: 2021-09-14
Primary completion: 2024-10-31
Enrollment: 193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.